CN206638677U - 一种用于术后病人监测的多指标快速检测胶体金试剂盒 - Google Patents
一种用于术后病人监测的多指标快速检测胶体金试剂盒 Download PDFInfo
- Publication number
- CN206638677U CN206638677U CN201720450274.XU CN201720450274U CN206638677U CN 206638677 U CN206638677 U CN 206638677U CN 201720450274 U CN201720450274 U CN 201720450274U CN 206638677 U CN206638677 U CN 206638677U
- Authority
- CN
- China
- Prior art keywords
- pad
- detection
- colloidal gold
- postoperative patient
- patient monitoring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 100
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 238000012544 monitoring process Methods 0.000 title claims abstract description 28
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 27
- 239000010931 gold Substances 0.000 claims abstract description 26
- 229910052737 gold Inorganic materials 0.000 claims abstract description 26
- 230000021615 conjugation Effects 0.000 claims abstract description 21
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 claims abstract description 12
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 claims abstract description 12
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 claims abstract description 12
- 102000019298 Lipocalin Human genes 0.000 claims abstract description 10
- 108050006654 Lipocalin Proteins 0.000 claims abstract description 10
- 102000013382 Gelatinases Human genes 0.000 claims abstract description 9
- 108010026132 Gelatinases Proteins 0.000 claims abstract description 9
- 108010048233 Procalcitonin Proteins 0.000 claims abstract description 9
- 210000004493 neutrocyte Anatomy 0.000 claims abstract description 9
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 claims abstract description 9
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical group C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 claims abstract description 8
- 239000011248 coating agent Substances 0.000 claims description 20
- 238000000576 coating method Methods 0.000 claims description 20
- 238000002615 hemofiltration Methods 0.000 claims description 16
- 239000000427 antigen Substances 0.000 claims description 14
- 102000036639 antigens Human genes 0.000 claims description 13
- 108091007433 antigens Proteins 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 11
- 239000003365 glass fiber Substances 0.000 claims description 7
- 239000004745 nonwoven fabric Substances 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 4
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 239000000020 Nitrocellulose Substances 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 229920001220 nitrocellulos Polymers 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 abstract description 18
- 102000013519 Lipocalin-2 Human genes 0.000 abstract description 14
- 108010051335 Lipocalin-2 Proteins 0.000 abstract description 14
- 206010061218 Inflammation Diseases 0.000 abstract description 13
- 230000004054 inflammatory process Effects 0.000 abstract description 13
- 208000001647 Renal Insufficiency Diseases 0.000 abstract description 9
- 238000003745 diagnosis Methods 0.000 abstract description 9
- 201000006370 kidney failure Diseases 0.000 abstract description 9
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract description 6
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract description 6
- 238000001356 surgical procedure Methods 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 201000011040 acute kidney failure Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 208000009304 Acute Kidney Injury Diseases 0.000 description 4
- 208000033626 Renal failure acute Diseases 0.000 description 4
- 208000012998 acute renal failure Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 230000009692 acute damage Effects 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000007675 cardiac surgery Methods 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 208000012866 low blood pressure Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 102100026882 Alpha-synuclein Human genes 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 108090000185 alpha-Synuclein Proteins 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036228 toxication Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201720450274.XU CN206638677U (zh) | 2017-04-26 | 2017-04-26 | 一种用于术后病人监测的多指标快速检测胶体金试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201720450274.XU CN206638677U (zh) | 2017-04-26 | 2017-04-26 | 一种用于术后病人监测的多指标快速检测胶体金试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN206638677U true CN206638677U (zh) | 2017-11-14 |
Family
ID=60246122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201720450274.XU Active CN206638677U (zh) | 2017-04-26 | 2017-04-26 | 一种用于术后病人监测的多指标快速检测胶体金试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN206638677U (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021218661A1 (zh) * | 2020-04-30 | 2021-11-04 | 吉林省格瑞斯特生物技术有限公司 | G-17、pgi、pgii联合检测装置及其制备方法 |
-
2017
- 2017-04-26 CN CN201720450274.XU patent/CN206638677U/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021218661A1 (zh) * | 2020-04-30 | 2021-11-04 | 吉林省格瑞斯特生物技术有限公司 | G-17、pgi、pgii联合检测装置及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107383192B (zh) | 半乳糖凝集素-3检测试剂盒 | |
CN111024954A (zh) | 联合检测covid-19抗原和抗体的胶体金免疫层析装置及其使用法 | |
CA2788636C (en) | Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients | |
WO2010036930A1 (en) | Methods and kits for detecting joint infection | |
CN107045062B (zh) | 检测人ngal的胶体金免疫层析试纸条、试剂盒及其制备方法 | |
CN104865384A (zh) | 一种快速检测肾衰的三联试剂盒及其制备方法与应用 | |
EP1424558A1 (en) | Reagent for assaying laminin 5 antigen in biological sample and assay method | |
DE60114823T2 (de) | Inter-alpha-trypsin als marker für sepsis | |
CN108845143A (zh) | 一种pct-crp双联卡及其制备方法 | |
CN206638678U (zh) | 用于术后病人监测的多指标时间分辨荧光免疫层析试剂盒 | |
CN206638677U (zh) | 一种用于术后病人监测的多指标快速检测胶体金试剂盒 | |
CN107271692B (zh) | 一种标记特异性高亲和力重组抗体的荧光微球及其应用 | |
CN115353566B (zh) | 用于检测白细胞介素1-β的抗体组合及其应用 | |
CN206804667U (zh) | 一种用于肾衰快速定量检测的多指标时间分辨荧光免疫层析试剂盒 | |
CN202837303U (zh) | Ngal荧光免疫层析定量检测试纸条 | |
KR101142434B1 (ko) | 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법 | |
CN108761082A (zh) | 一种定量检测血清lrpprc的抗体组合及试剂盒 | |
CN208399511U (zh) | 一种用于脓毒症快速定量检测的胶体金试剂盒 | |
CN206725582U (zh) | 一种用于糖尿病人心肾功能监测的胶体金试剂盒 | |
CN206772984U (zh) | 一种用于急性肾损伤快速定量检测的多指标胶体金试剂盒 | |
CN206638683U (zh) | 用于糖尿病人心肾功能监测的多指标时间分辨荧光免疫层析试剂盒 | |
JP5857385B2 (ja) | Ape1/ref−1を含有する膀胱癌診断用組成物、及びこれを利用した膀胱癌診断キット | |
CN206772987U (zh) | 一种用于急性肾损伤快速定量检测的多指标时间分辨荧光免疫层析试剂盒 | |
CN106324257A (zh) | 一种检测犬NT‑proBNP的试纸条及其制备方法 | |
CN105242049A (zh) | 一种鉴别诊断急性支原体、细菌和病毒感染的试剂盒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Assignor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Contract record no.: X2023320010012 Denomination of utility model: A multi-index rapid detection colloidal gold kit for postoperative patient monitoring Granted publication date: 20171114 License type: Exclusive License Record date: 20230110 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: A multi-index rapid detection colloidal gold kit for postoperative patient monitoring Effective date of registration: 20230111 Granted publication date: 20171114 Pledgee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Pledgor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Registration number: Y2023320010031 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Assignor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Contract record no.: X2023320010012 Date of cancellation: 20240203 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20171114 Pledgee: Jiangsu Jinmao Finance Leasing Co.,Ltd. Pledgor: JIANGSU YANGXIN BIOMEDICAL CO.,LTD. Registration number: Y2023320010031 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |